Industry NewsLife Sciences
Fluidic Sciences acquires business and assets of Sphere Bio
Combined portfolio unites Fluidic Sciences’ in‑solution microfluidic diffusional sizing technology with Sphere Bio’s proprietary picodroplet-microfluidic platforms, Cyto‑Mine Chroma, and high‑throughput assays – delivering end‑to‑end insight from cells to molecules
View article